Drug Database
Back to search

Finland· FI-REL-REL10468

Buspiron ratiopharm

A buspirone product containing buspirone hydrochloride, registered in Finland by Teva B.V.. The same ATC class is registered in 12 of our 19 countries.

ATC N05BE01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedBuspiron ratiopharmATCN05BE01REGISTER NO.FI-REL-REL10468PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about buspirone hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Buspirone is registered in 12 of 19 countries.

Countries holding a registration under ATC N05BE01 (buspirone), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 6 of them publish a price we can compare per daily dose
Search buspirone products by name

Buspirone · ATC N05BE01

12 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of buspirone costs, country by country.

Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Buspirone · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • FR France$0.60
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Buspirone hydrochloride
Manufacturer
Teva B.V.
Country
Finland (FI)
ATC code
N05BE01
ATC class
Buspirone
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • fi_myyntilupa
    593175
    100
    EUR 33.09

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

258 interactions on record for buspirone.

Graded by severity as the source publishes them — 22 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check buspirone against other medicinesHow interaction checks work

Buspirone · interactions on record

258 records

  • 22 severe
  • 118 moderate
  • 118 info

Most severe, free to view

  • OndansetronA04AA01severe
  • GranisetronA04AA02severe
  • DolasetronA04AA04severe
  • PalonosetronA04AA05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Buspirone in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All buspirone products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Czechia · Buspiron-Egis
  • Germany · Busp
  • Denmark · Buripal, Buspiron Actavis
  • France · Buspirone Sandoz, Buspirone Viatris
  • United Kingdom (Northern Ireland) · Buspirone Accord-Uk, Buspirone Hydrochloride
  • Greece · Antipsichos, Bergamol
  • Hungary · Spitomin
  • Lithuania · Spitomin
  • Latvia · Spitomin
  • Netherlands · Buspiron Hcl Cf, Buspiron Hcl Mylan
  • Norway · Buripal, Buspirone Orion
  • Poland · Spamilan
  • Portugal · Ansiten, Busansil
  • Romania · Spitomin
  • Sweden · Anksilon, Buripal
  • Slovakia · Spitomin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f935f674-f7cf-4473-a76f-2d96d9d91010
GET /v1/drugs/f935f674-f7cf-4473-a76f-2d96d9d91010?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "30",
  "form": "tabletti",
  "route": "Suun kautta",
  "ddd_unit": "mg",
  "strength": "5 mg",
  "atc_label": "buspironi",
  "ma_number": "13642",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL10468",
  "authorised_at": "1999-01-18"
}
API referenceMCP serverPlans

See everything about buspirone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console